Yuki Gosei KogyoYUKI GOSEI KOGYO CO.,LTD.4531東証スタンダード医薬品FY ending Mar 2026, non-consolidated, J-GAAP

Yuki Gosei Kogyo FY ending Mar 2020 results

Yuki Gosei Kogyo brought in ¥10.7B in revenue.

Out of every ¥100 of sales, about ¥3 is left as operating profit.

Where the money goes

For every ¥100 Yuki Gosei Kogyo sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 21.5% → Operating margin 2.9% → Net margin -0.4%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第104期(2023/04/01－2024/03/31)
ID S100TQ3M2024-06-24Open
EDINET (FSA Japan)
有価証券報告書－第102期(令和3年4月1日－令和4年3月31日)
ID S100OCIF2022-06-22Open
EDINET (FSA Japan)
訂正有価証券報告書－第101期(令和2年4月1日－令和3年3月31日)
ID S100LY8W2021-07-08Open

Extracted from XBRL: 42 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.